Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.

  • 1 January 1980
    • journal article
    • clinical trial
    • p. 93-8
Abstract
No abstract available

This publication has 0 references indexed in Scilit: